(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of -1.51% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.65%.
Neogen's revenue in 2025 is $894,661,000.On average, 2 Wall Street analysts forecast NEOG's revenue for 2026 to be $178,638,233,174, with the lowest NEOG revenue forecast at $177,391,475,406, and the highest NEOG revenue forecast at $179,884,990,941. On average, 3 Wall Street analysts forecast NEOG's revenue for 2027 to be $182,225,594,026, with the lowest NEOG revenue forecast at $180,562,671,122, and the highest NEOG revenue forecast at $184,435,439,588.
In 2028, NEOG is forecast to generate $185,601,831,437 in revenue, with the lowest revenue forecast at $185,558,390,400 and the highest revenue forecast at $185,645,272,474.